These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25185420)

  • 1. Evaluation of six PCR assays in combination with patient related data for the diagnosis of Clostridium difficile-associated infections.
    Eigner U; Fenner I; Veldenzer A; Schwarz R; Oberdorfer K; Holfelder M
    Clin Lab; 2014; 60(8):1343-50. PubMed ID: 25185420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with laboratory diagnosis of Clostridium difficile].
    Bareková L; Zálabská E; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA?
    Orendi JM; Monnery DJ; Manzoor S; Hawkey PM
    J Hosp Infect; 2012 Jan; 80(1):82-4. PubMed ID: 22104474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage algorithm for Clostridium difficile: glutamate-dehydrogenase-positive toxin-negative enzyme immunoassay results may require further testing.
    Bignardi GE; Hill K; Berrington A; Settle CD
    J Hosp Infect; 2013 Apr; 83(4):347-9. PubMed ID: 23399483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections.
    Hernández-Rocha C; Barra-Carrasco J; Álvarez-Lobos M; Paredes-Sabja D; Guzmán-Durán AM
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):361-5. PubMed ID: 23415540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utilities of a fully automated molecular test for toxigenic Clostridium difficile.
    Morinaga Y; Akamatsu N; Matsuda J; Tateno H; Tomaru T; Tanaka A; Morita S; Nakamura M; Kato H; Annaka M; Masuda Y; Itakura Y; Inamatsu T; Yanagihara K
    J Infect Chemother; 2018 Feb; 24(2):88-91. PubMed ID: 28974364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection.
    Berry N; Sewell B; Jafri S; Puli C; Vagia S; Lewis AM; Davies D; Rees E; Ch'ng CL
    J Hosp Infect; 2014 Jun; 87(2):109-14. PubMed ID: 24795170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?
    Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ
    Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor yield of Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays in a pediatric population with declining prevalence of clostridium difficile strain BI/NAP1/027.
    Gomez EJ; Montgomery S; Alby K; Robinson DP; Roundtree SS; Blecker-Shelly D; Sullivan KV
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):229-232. PubMed ID: 29567127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
    Olling A; Leidinger H; Hoffmann R
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1655-9. PubMed ID: 27323765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evaluation of the Performance of C. Diff Quik Chek Complete and Toxin A + B (Clostridium difficile) DUO Diagnostic Tests Compared with Toxigenic Culture in the Diagnosis of Clostridium difficile Infection.
    Yazisiz H; Özyurt ÖK; Öngüt G; Baysan BÖ; Dönmez L; Günseren F; Çolak D; Öğünç D
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance Comparison of a Novel Rapid Stand-alone Molecular Test and a 2-Step Diagnostic Algorithm for Clostridioides difficile Detection in Children.
    Brotons P; Saucedo J; Simó S; Gené A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2021 Feb; 40(2):169-172. PubMed ID: 33055503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.